+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Digital PCR (dPCR) Market 2020-2024

  • PDF Icon

    Report

  • 120 Pages
  • January 2020
  • Region: Global
  • TechNavio
  • ID: 4938437
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Global Digital PCR (dPCR) Market 2020-2024

The author has been monitoring the global digital PCR (dPCR) market and it is poised to grow by USD 252.26 mn during 2020-2024, progressing at a CAGR of 11% during the forecast period. The reports on global digital PCR (dPCR) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing use of dPCR in pathogen detection and disease diagnosis. In addition, growing applications of beaming technology-based dPCR workflows is anticipated to boost the growth of the global digital PCR (dPCR) market as well.

Market Segmentation

The global digital PCR (dPCR) market is segmented as below:

Product
  • Consumables
  • Instruments

Geographic segmentation
  • North America
  • Europe
  • Asia
  • ROW

Key Trends for global digital PCR (dPCR) market growth
This study identifies growing applications of beaming technology-based dPCR workflows as the prime reasons driving the global digital PCR (dPCR) market growth during the next few years.

Prominent vendors in global digital PCR (dPCR) market
We provide a detailed analysis of around 25 vendors operating in the global digital PCR (dPCR) market, including some of the vendors such as Bio-Rad Laboratories Inc., Expedeon AG, Fluidigm Corp., JN Medsys, Merck KGaA, QIAGEN NV, Stilla Technologies, Sysmex Corp. and Thermo Fisher Scientific Inc.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Table of Contents

01: EXECUTIVE SUMMARY
02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$

03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
  • Value chain analysis

04: MARKET SIZING
  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024
  • Market outlook

05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

06: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • Consumables - Market size and forecast 2019-2024
  • Instruments - Market size and forecast 2019-2024
  • Market opportunity by product

07: CUSTOMER LANDSCAPE
08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

09: DECISION FRAMEWORK
10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges

11: MARKET TRENDS
  • Growing applications of BEAMing technology-based dPCR workflows
  • Growing developments in personalized medicine
  • Growing demand for dPCR in non-invasive prenatal diagnosis

12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario

13: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Bio-Rad Laboratories Inc.
  • Expedeon AG
  • Fluidigm Corp.
  • JN Medsys
  • Merck KGaA
  • QIAGEN NV
  • Stilla Technologies
  • Sysmex Corp.
  • Thermo Fisher Scientific Inc.

14: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

List of Exhibits
Exhibit 01: Global life sciences tools and services market
Exhibit 02: Segments of global life sciences tools and services market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendor offerings
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2019
Exhibit 18: Product - Market share 2019-2024 (%)
Exhibit 19: Comparison by product
Exhibit 20: Consumables - Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Consumables - Year-over-year growth 2020-2024 (%)
Exhibit 22: Instruments - Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Instruments - Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
Exhibit 30: Europe - Market size and forecast 2019-2024 ($ millions)
Exhibit 31: Europe - Year-over-year growth 2020-2024 (%)
Exhibit 32: Asia - Market size and forecast 2019-2024 ($ millions)
Exhibit 33: Asia - Year-over-year growth 2020-2024 (%)
Exhibit 34: ROW - Market size and forecast 2019-2024 ($ millions)
Exhibit 35: ROW - Year-over-year growth 2020-2024 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Impact of drivers and challenges
Exhibit 39: Vendor landscape
Exhibit 40: Landscape disruption
Exhibit 41: Vendors covered
Exhibit 42: Vendor classification
Exhibit 43: Market positioning of vendors
Exhibit 44: Bio-Rad Laboratories Inc. - Vendor overview
Exhibit 45: Bio-Rad Laboratories Inc. - Business segments
Exhibit 46: Bio-Rad Laboratories Inc. - Organizational developments
Exhibit 47: Bio-Rad Laboratories Inc. - Geographic focus
Exhibit 48: Bio-Rad Laboratories Inc. - Segment focus
Exhibit 49: Bio-Rad Laboratories Inc. - Key offerings
Exhibit 50: Expedeon AG - Vendor overview
Exhibit 51: Expedeon AG - Business segments
Exhibit 52: Expedeon AG - Organizational developments
Exhibit 53: Expedeon AG - Geographic focus
Exhibit 54: Expedeon AG - Key offerings
Exhibit 55: Fluidigm Corp. - Vendor overview
Exhibit 56: Fluidigm Corp. - Product segments
Exhibit 57: Fluidigm Corp. - Organizational developments
Exhibit 58: Fluidigm Corp. - Geographic focus
Exhibit 59: Fluidigm Corp. - Key offerings
Exhibit 60: JN Medsys - Vendor overview
Exhibit 61: JN Medsys - Product segments
Exhibit 62: JN Medsys - Key offerings
Exhibit 63: Merck KGaA - Vendor overview
Exhibit 64: Merck KGaA - Business segments
Exhibit 65: Merck KGaA - Organizational developments
Exhibit 66: Merck KGaA - Geographic focus
Exhibit 67: Merck KGaA - Segment focus
Exhibit 68: Merck KGaA - Key offerings
Exhibit 69: QIAGEN NV - Vendor overview
Exhibit 70: QIAGEN NV - Business segments
Exhibit 71: QIAGEN NV - Organizational developments
Exhibit 72: QIAGEN NV - Geographic focus
Exhibit 73: QIAGEN NV - Segment focus
Exhibit 74: QIAGEN NV - Key offerings
Exhibit 75: Stilla Technologies - Vendor overview
Exhibit 76: Stilla Technologies - Product segments
Exhibit 77: Stilla Technologies - Organizational developments
Exhibit 78: Stilla Technologies - Key offerings
Exhibit 79: Sysmex Corp. - Vendor overview
Exhibit 80: Sysmex Corp. - Business segments
Exhibit 81: Sysmex Corp. - Organizational developments
Exhibit 82: Sysmex Corp. - Geographic focus
Exhibit 83: Sysmex Corp. - Segment focus
Exhibit 84: Sysmex Corp. - Key offerings
Exhibit 85: Thermo Fisher Scientific Inc. - Vendor overview
Exhibit 86: Thermo Fisher Scientific Inc. - Business segments
Exhibit 87: Thermo Fisher Scientific Inc. - Organizational developments
Exhibit 88: Thermo Fisher Scientific Inc. - Geographic focus
Exhibit 89: Thermo Fisher Scientific Inc. - Segment focus
Exhibit 90: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 91: Validation techniques employed for market sizing
Exhibit 92: Definition of market positioning of vendors

Executive Summary

The following companies as the key players in the global digital PCR (dPCR) market: Bio-Rad Laboratories Inc., Expedeon AG, Fluidigm Corp., JN Medsys, Merck KGaA, QIAGEN NV, Stilla Technologies, Sysmex Corp. and Thermo Fisher Scientific Inc.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is growing applications of beaming technology-based dPCR workflows”

According to the report, one of the major drivers for this market is the increasing use of dPCR in pathogen detection and disease diagnosis.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Bio-Rad Laboratories Inc.
  • Expedeon AG
  • Fluidigm Corp.
  • JN Medsys
  • Merck KGaA
  • QIAGEN NV
  • Stilla Technologies
  • Sysmex Corp.
  • Thermo Fisher Scientific Inc.